Thierry Petit

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

Pierre Farmer, Hervé Bonnefoi, Pascale Anderle et al. · Nature Medicine · 2009 · 615 citations · Full text

Breast Oncology, Oncology, Engineering +11

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

Thierry Petit, M. Wilt, Michel Velten et al. · European Journal of Cancer · 2003 · 272 citations

Breast Oncology, Breast Cancer Patients, Medicine +9

RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

Hervé Bonnefoi, Anil Potti, Mauro Delorenzi et al. · The Lancet Oncology · 2007 · 218 citations · Full text

Breast Oncology, Medicine, Pathology +9

Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016

Élise Deluche, Alison Antoine, Thomas Bachelot et al. · European Journal of Cancer · 2020 · 180 citations

Metastatic Breast Cancer, Breast Oncology, Cancer Epidemiology +9

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

Xavier Pivot, Joseph Gligorov, Volkmar Müller et al. · Annals of Oncology · 2014 · 169 citations · Full text

Breast Oncology, Oncology, Conventional Intravenous Infusion +6